QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 4.8
-- x --
-- x --
-- - --
$ 3.00 - $ 11.80
2,172
na
nm
$ 0.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-18-2025 12-31-2022 10-K
2 11-07-2022 09-30-2022 10-Q
3 08-08-2022 06-30-2022 10-Q
4 05-09-2022 03-31-2022 10-Q
5 02-25-2022 12-31-2021 10-K
6 11-05-2021 09-30-2021 10-Q
7 08-06-2021 06-30-2021 10-Q
8 04-30-2021 03-31-2021 10-Q
9 02-26-2021 12-31-2020 10-K
10 10-30-2020 09-30-2020 10-Q
11 07-31-2020 06-30-2020 10-Q
12 05-08-2020 03-31-2020 10-Q
13 03-02-2020 12-31-2019 10-K
14 11-05-2019 09-30-2019 10-Q
15 08-09-2019 06-30-2019 10-Q
16 05-03-2019 03-31-2019 10-Q
17 02-22-2019 12-31-2018 10-K
18 11-02-2018 09-30-2018 10-Q
19 08-06-2018 06-30-2018 10-Q
20 05-08-2018 03-31-2018 10-Q
21 02-26-2018 12-31-2017 10-K
22 11-09-2017 09-30-2017 10-Q
23 08-04-2017 06-30-2017 10-Q
24 05-05-2017 03-31-2017 10-Q
25 02-27-2017 12-31-2016 10-K
26 11-04-2016 09-30-2016 10-Q
27 08-05-2016 06-30-2016 10-Q
28 05-06-2016 03-31-2016 10-Q
29 02-29-2016 12-31-2015 10-K
30 11-06-2015 09-30-2015 10-Q
31 08-05-2015 06-30-2015 10-Q
32 05-08-2015 03-31-2015 10-Q
33 03-02-2015 12-31-2014 10-K
34 11-07-2014 09-30-2014 10-Q
35 08-08-2014 06-30-2014 10-Q
36 05-09-2014 03-31-2014 10-Q
37 03-03-2014 12-31-2013 10-K
38 11-12-2013 09-30-2013 10-Q
39 08-09-2013 06-30-2013 10-Q
40 05-10-2013 03-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stephens--co-maintains-equal-weight-on-veradigm-raises-price-target-to-13

Stephens & Co. analyst Jeff Garro maintains Veradigm (OTC:MDRX) with a Equal-Weight and raises the price target from $7 ...

Core News & Articles

https://www.axios.com/pro/health-tech-deals/2024/11/10/mckesson-oracle-veradigm-bidders-allscripts

 td-cowen-maintains-buy-on-veradigm-lowers-price-target-to-15

TD Cowen analyst Charles Rhyee maintains Veradigm (OTC:MDRX) with a Buy and lowers the price target from $26 to $15.

 deutsche-bank-downgrades-veradigm-to-hold-lowers-price-target-to-10

Deutsche Bank analyst George Hill downgrades Veradigm (OTC:MDRX) from Buy to Hold and lowers the price target from $15 to $10.

Core News & Articles

Veradigm will be suspended from the Nasdaq Stock Market on February 29 due to non-compliance with NASDAQ listing rules and is n...

 veradigm-signs-definitive-agreement-to-acquire-scienceio-for-purchase-price-to-be-paid-of-140m-cash

The transaction will be funded through cash on hand and is not subject to a financing condition. The purchase price to be paid ...

 veradigm-expects-not-to-file-required-financial-statements-by-nasdaqs-february-27-2024-deadline-says-working-diligently-to-file-required-financial-statements-and-restore-listing

The Company also announced that its Board of Directors has unanimously adopted a limited duration stockholder rights plan in an...

 veradigm-and-american-college-of-cardiology-launch-influenza-vaccination-education-initiative-to-improve-cardiovascular-health

Veradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANS...

 rbc-capital-maintains-outperform-on-veradigm-lowers-price-target-to-11

RBC Capital analyst Sean Dodge maintains Veradigm (NASDAQ:MDRX) with a Outperform and lowers the price target from $22 to $11.

 why-wd-40-shares-are-trading-higher-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected ...

 why-healthcare-data--technology-solutions-provider-veradigm-shares-are-trading-lower-today

Veradigm Inc (NASDAQ: MDRX) shares are trading lower after it provided 

 veradigm-aehr-test-systems-saratoga-investment-and-other-big-stocks-moving-lower-on-wednesday

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NA...

 veradigm-partners-with-medallies
Veradigm Partners With MedAllies
01/09/2024 14:13:32

Providers using Veradigm EHRs to gain access to longitudinal patient records, improving interoperability and driving better tre...

 barclays-initiates-coverage-on-veradigm-with-equal-weight-rating-announces-price-target-of-11

Barclays analyst Stephanie Davis initiates coverage on Veradigm (NASDAQ:MDRX) with a Equal-Weight rating and announces Price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION